Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Merck
Mallinckrodt
Dow
Harvard Business School

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

FLUOCINOLONE ACETONIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Fluocinolone Acetonide patents expire, and when can generic versions of Fluocinolone Acetonide launch?

Fluocinolone Acetonide is a drug marketed by Allied, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Perrigo New York, Pharmafair, Taro, Usl Pharma, Akorn, Amneal, Lyne, Padagis Israel, Quagen, Tasman Pharma, Pharmaderm, Actavis Labs Ut Inc, Bausch And Lomb, Encube Ethicals, Glasshouse Pharms, Lupin, and Morton Grove. and is included in fifty-three NDAs.

The generic ingredient in FLUOCINOLONE ACETONIDE is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fluocinolone Acetonide

A generic version of FLUOCINOLONE ACETONIDE was approved as fluocinolone acetonide by TARO on April 27th, 1982.

  Try it Free

Drug patent expirations by year for FLUOCINOLONE ACETONIDE
Drug Prices for FLUOCINOLONE ACETONIDE

See drug prices for FLUOCINOLONE ACETONIDE

Recent Clinical Trials for FLUOCINOLONE ACETONIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre Hospitalier Universitaire DijonPhase 4
Lee's Pharmaceutical LimitedPhase 3
St. Michael's Hospital, TorontoPhase 2

See all FLUOCINOLONE ACETONIDE clinical trials

Pharmacology for FLUOCINOLONE ACETONIDE
Medical Subject Heading (MeSH) Categories for FLUOCINOLONE ACETONIDE

US Patents and Regulatory Information for FLUOCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma FLUOCINOLONE ACETONIDE fluocinolone acetonide OINTMENT;TOPICAL 088742-001 Feb 8, 1985 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Quagen FLUOCINOLONE ACETONIDE fluocinolone acetonide OIL;TOPICAL 212760-001 Apr 2, 2021 AT RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Glasshouse Pharms FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 209596-001 Dec 26, 2017 AT RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Johnson and Johnson
Moodys
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.